The Preserve Access to Affordable Generics and Biosimilars Act: It’s Back! And Bigger and Bolder than Before!
FDA Law Blog
MARCH 31, 2025
2233 (2013) , that so-called reverse payment settlement agreements are presumptively unlawful. EO 14215 requires employees of agencies, like the FTC, to consult with the USAG on interpretations of the law and removes any agency authority to advance its own legal positions without consultation. Actavis, Inc.,
Let's personalize your content